IntelGenx Technologies Corp (IGXT)

[railroadman]

During 2016 IGXT made progress on many fronts. Added and strenghten the management team.
Enhanced communications with shareholders, moved to a new facility, installed new state of the art production equipment to reduced cost of goods sold. Equipment is being validated.

Commercial efforts are very sizable.
sold off for cash but retain IP, for Forfivo.
I deal with Par.

2 Rizaport deals and options for many more countries to be added.

Four deals with Chemo.

IGXT has 7 commercial drivers behind them as 2016 closes out.

More to come.

Major catalysts coming during 2017!!!

FDA submission for Migraine film. Maybe a commercial deal close at hand.

ED film product moving along nicely. Commercial deal/deals will be signed this year.

Montelukast repuposing efforts moving along. Phase 2 trails being in 1st quarter.
Company strategic focus delaying any deals until value of trials is confirmed and released to Market.

Once validated, major pharma's will be energized to come to commerical agreement with this potential blockbuster.

Lastly, company has many revenue drivers going forward. Wont be much longer until the institutions start taking large positions.

Happy holidays to all. 2017 and 2018 are milestone years. RRM